Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.

dc.contributor.author

Sheppard, Vanessa B

dc.contributor.author

He, Jun

dc.contributor.author

Sutton, Arnethea

dc.contributor.author

Cromwell, Lee

dc.contributor.author

Adunlin, Georges

dc.contributor.author

Salgado, Teresa M

dc.contributor.author

Tolsma, Dennis

dc.contributor.author

Trout, Martha

dc.contributor.author

Robinson, Brandi E

dc.contributor.author

Edmonds, Megan C

dc.contributor.author

Bosworth, Hayden B

dc.contributor.author

Tadesse, Mahlet G

dc.date.accessioned

2024-01-26T00:00:17Z

dc.date.available

2024-01-26T00:00:17Z

dc.date.issued

2019-05

dc.description.abstract

Background

Adjuvant endocrine therapy (AET) is a critical therapy in that it improves survival in women with hormone receptor-positive (HR+) breast cancer (BC), but adherence to AET is suboptimal. The purpose of this study was to fill scientific gaps about predictors of adherence to AET among black and white women diagnosed with BC.

Objective

To assess AET adherence in black and white insured women using multiple measures, including one that uses an innovative statistical approach.

Methods

Black and white women newly diagnosed with HR+ BC were identified from 2 health maintenance organizations. Pharmacy records captured the type of oral AET prescriptions and all fill dates. Multivariable logistic regression was used to identify predictors of adherence defined in terms of proportion of days covered (PDC; ≥ 80%) and medication gap of ≤ 10 days. A zero-inflated negative binomial (ZINB) regression model was used to identify variables associated with the total number of days of medication gaps.

Results

1,925 women met inclusion criteria. 80% were PDC adherent (> 80%); 44% had a medication gap of ≤ 10 days; and 24% had no medication gap days. Race and age were significant in all multivariable models. Black women were less likely to be adherent based on PDC than white women (OR = 0.72, 95% CI = 0.57-0.90, P < 0.01), and they were less likely to have a medication gap of ≤ 10 days (OR = 0.65, 95% CI = 0.54-0.79, P < 0.001). Women aged 25-49 years were less likely to be PDC adherent than women aged 65-93 years (OR = 0.65, 95% CI = 0.48-0.87, P < 0.001). In the ZINB model, women were without their medication for an average of 37 days (SD = 50.5).

Conclusions

Racial disparities in adherence to AET in the study highlight a need for interventions among insured women. Using various measures of adherence may help better understand this multidimensional concept. There might be benefits from using both more common dichotomous measures (e.g., PDC) and integrating novel statistical approaches to allow tailoring adherence to patterns within a specific sample.

Disclosures

This research was funded by the National Institutes of Health (R01CA154848). It was also supported in part by the NIH-NCI Cancer Center Support Grant P30 CA016059, the Laboratory of Telomere Health P30 CA51008, and the TSA Award No. UL1TR002649 from the National Center for Advancing Translational Sciences. The contents of this study are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. Bosworth reports grants from Sanofi, Otsuka, Johnson & Johnson, and Blue Cross/Blue Shield of NC and consulting fees from Sanofi and Otsuka. The other authors have nothing to disclose. The datasets generated during and/or analyzed during the current study are not publicly available due to privacy reasons but are available from the corresponding author on reasonable request. The author does not own these data. Data use was granted to the author as part of a data use agreement between specific agencies and organizations.
dc.identifier.issn

2376-0540

dc.identifier.issn

2376-1032

dc.identifier.uri

https://hdl.handle.net/10161/29866

dc.language

eng

dc.publisher

Academy of Managed Care Pharmacy

dc.relation.ispartof

Journal of managed care & specialty pharmacy

dc.relation.isversionof

10.18553/jmcp.2019.25.5.578

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Humans

dc.subject

Breast Neoplasms

dc.subject

Receptors, Estrogen

dc.subject

Receptors, Progesterone

dc.subject

Antineoplastic Agents, Hormonal

dc.subject

Chemotherapy, Adjuvant

dc.subject

Mastectomy

dc.subject

Survival Analysis

dc.subject

Retrospective Studies

dc.subject

Adult

dc.subject

Aged

dc.subject

Aged, 80 and over

dc.subject

Middle Aged

dc.subject

United States

dc.subject

Female

dc.subject

Health Status Disparities

dc.subject

Medication Adherence

dc.subject

Cancer Survivors

dc.subject

White People

dc.subject

Black or African American

dc.title

Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.

dc.type

Journal article

duke.contributor.orcid

Bosworth, Hayden B|0000-0001-6188-9825

pubs.begin-page

578

pubs.end-page

586

pubs.issue

5

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Center for the Study of Aging and Human Development

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.organisational-group

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

pubs.organisational-group

Duke - Margolis Center For Health Policy

pubs.publication-status

Published

pubs.volume

25

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors Exploring Adherence Measures in P.pdf
Size:
251.86 KB
Format:
Adobe Portable Document Format